Johnson T S, Rock P B, Young J B, Fulco C S, Trad L A
Thorndike Laboratory, Department of Medicine, Beth Israel Hospital, Massachusetts.
Aviat Space Environ Med. 1988 Mar;59(3):208-12.
Altitude exposure alters hemodynamics and sympathoadrenal function and elicits acute mountain sickness (AMS). Since dexamethasone prevents AMS and influences responsiveness to catecholamines, we studied hemodynamic and sympathoadrenal responses to 4,570 m simulated altitude in 8 subjects treated with dexamethasone or placebo. Mean pulse rates were less at altitude with dexamethasone (96.1 for placebo and 84.1 for dexamethasone; treatment-altitude interaction, p = 0.0045). Altitude led to a postural decline in mean arterial pressure (posture-altitude interaction, p = 0.0026), but this was not affected by dexamethasone. Dexamethasone reduced urinary epinephrine to a greater extent during altitude exposure (from 9.41 ng.mg-1 creatinine with placebo to 4.16 with dexamethasone) when compared with sea level (from 3.24 to 3.08). Urinary excretion of norepinephrine was unchanged at altitude. We conclude that acute altitude exposure is associated with stimulation of the adrenal medulla and not the sympathetic nervous system. Dexamethasone blocks the adrenal medullary response and blunts the pulse rate increase at altitude.
暴露于高原环境会改变血液动力学和交感肾上腺功能,并引发急性高山病(AMS)。由于地塞米松可预防急性高山病并影响对儿茶酚胺的反应性,我们研究了8名接受地塞米松或安慰剂治疗的受试者在模拟海拔4570米高度时的血液动力学和交感肾上腺反应。使用地塞米松时,高原地区的平均脉搏率较低(安慰剂组为96.1,地塞米松组为84.1;治疗-海拔交互作用,p = 0.0045)。高原导致平均动脉压出现体位性下降(体位-海拔交互作用,p = 0.0026),但这不受地塞米松影响。与海平面相比(从3.24降至3.08),地塞米松在高原暴露期间更大程度地降低了尿肾上腺素水平(从安慰剂组的9.41纳克·毫克⁻¹肌酐降至地塞米松组的4.16)。高原地区去甲肾上腺素的尿排泄量未发生变化。我们得出结论,急性高原暴露与肾上腺髓质而非交感神经系统的刺激有关。地塞米松可阻断肾上腺髓质反应,并减弱高原时脉搏率的增加。